Evidence map›Paper›PMID 36651778›Full record

ArticleMicrobiology spectrum2023

Whole Genome-Based Characterization of Multidrug Resistant Enterobacter and Klebsiella aerogenes Isolates from Lebanon.

Georgi Merhi, Sara Amayri, Ibrahim Bitar, George F Araj, Sima Tokajian

Abstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. ASM case reports · 2026
    Article
  5. Heteroresistance to amikacin inMicrobiology spectrum · 2026
    Article
  6. Article
  7. Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Comparative Genomics of an Emerging Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Genomic Epidemiology of Carbapenem-ResistantAntimicrobial agents and chemotherapy · 2023
    Article
  16. The emergence of carbapenemase-producingFrontiers in public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georgi Merhi *Department of Natural Sciences, Lebanese American University, Byblos, Lebanon.
Sara Amayri *Department of Natural Sciences, Lebanese American University, Byblos, Lebanon.
Ibrahim Bitar *Department of Microbiology, Faculty of Medicine, and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
George F ArajDepartment of Pathology & Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Sima TokajianDepartment of Natural Sciences, Lebanese American University, Byblos, Lebanon.ORCID 0000-0002-3653-8940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enterobacter spp. and Klebsiella aerogenes are rod-shaped Gram-negative opportunistic pathogens. This study aimed at the molecular and genomic characterization of multidrug resistant Enterobacter spp. and K. aerogenes isolates recovered from hospitalized patients in a tertiary care hospital in Lebanon. A total of 59 Enterobacter spp. clinical isolates consisting of 41 carbapenem-resistant and 18 susceptible by Etest were included in this study. Genotypic identification through whole-genome sequencing (WGS) was performed and confirmed

Indexed as

Enterobacter aerogenesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsEnterobacterHumansKlebsiella pneumoniaeLebanonMicrobial Sensitivity TestsMultilocus Sequence TypingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsEnterobacterESBLKlebsiella aerogenesmultidrug resistanceβ-lactamases

Identifiers

PMID36651778
PMCPMC9927356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.